Take the first step toward feeling your best, schedule your appointment with a primary care or obesity medicine provider, and discover whats possible for your health
follow the instructions of your clinical teams
Referral Links for What Exactly Is Retatrutide? Learn more about GLP-1/GIP/Glucagon triple-agonist therapies TripleHormone-Receptor Agonist Retatrutide for Obesity See how Retatrutide compares to Semaglutide & Tirzepatide Eli Lilly Overview of Retatrutide Mechanism & Research Background on Triple-Agonist Peptide Development Scientific Review: Triple-Hormone Agonists for Obesity Safety profile and metabolic benefits overview PubMed: Retatrutide Safety, Tolerability & Metabolic Outcomes Patient-friendly explanation of emerging weight-loss peptides FDAs Concerns with Unapproved GLP-1 Drugs Used for Weight Loss Before & After Transformations Real Patient Results Real people, REAL RESULTS
As a world-class athlete, entrepreneur, and mother, she's no stranger to discipline and resilience
designed a phase 1b, multiple-ascending dose study in type 2 diabetic patients [40]
Researchers use Semaglutide when studying isolated GLP-1R pharmacology, and Retatrutide when studying the combined tri-receptor incretin system, energy expenditure mechanisms, and the full scope of multi-pathway metabolic regulation
